July 26, 2016
CMIC HOLDINGS Co., Ltd.
MEDINET Co., Ltd.
CMIC HOLDINGS Co., Ltd. (“CMIC”) and MEDINET Co., Ltd. (“MEDINET”) announced that they have signed Business Alliance Agreement for health and medical care fields of regenerative medicine and cell therapy.
Details and Background of the Business Alliance
Our Approaches of Regenerative Medicine Fields
Our Services by the Business Alliance
【CMIC HOLDINGS Co., Ltd.】
CMIC Group started business in 1992 as the first CRO in Japan, and the company today provides comprehensive support services for development, manufacturing, sales, and marketing of pharmaceutical products. Also, the company operates to respond to diversifying needs by managing the Healthcare Business sector and developing and selling diagnostic pharmaceuticals and orphan drugs. CMIC Group has developed a unique business model that we call “Pharmaceutical Value Creator (PVC)” based on our abundant accumulated experience and knowledge as a CRO pioneer. CMIC utilize PVC to create new value in the healthcare field.
For more information, visit our website: https://www.cmicgroup.com/e/
【MEDINET Co., Ltd.】
MEDINET has provided a comprehensive service, which includes technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy, to medical institutions as Immuno-Cell Therapy Total Support Service since 1999. With our experience and knowledge in over 160,000 cases with no sever accident, MEDINET offers a range of solutions for the regenerative medicine and cell therapy industries, from pre-clinical research through to development and clinical trial manufacturing, and commercial launch in Japan.
Contact Us
CMIC HOLDINGS Co., Ltd.
Corporate Communication Division PR Group
Tel : +81-3-6779-8200 / E-mail: irpr@cmic.co.jp
MEDINET Co., Ltd.
Corporate Strategy Department
Tel : +81-45-478-0041 / E-mail: info-cmo@medinet-inc.co.jp